Deprescribing & Polypharmacy at APNA 40th Annual Conference
5 sessions on deprescribing & polypharmacy · October 28–31, 2026, Phoenix, AZ. Compare deprescribing & polypharmacy at other meetings →
Wednesday, October 28
Workshop · Practice
Decoding Deprescribing Guidelines: Best Prescribing Practices 2026
Synthesizes current deprescribing recommendations across drug classes and age groups, integrating both RN and APRN roles. Pharmacology-eligible.
Workshop · Psychopharmacology
Everything Benzodiazepines: A Comprehensive Update for 2026
Full update on benzodiazepine prescribing trends, safety evidence, and structured discontinuation strategies. Pharmacology-eligible.
Lecture · Outpatient
Do No Harm: A Safer Approach to Deprescribing Antidepressants
Distinguishes antidepressant withdrawal from relapse and introduces hyperbolic tapering for safer discontinuation. Pharmacology-eligible.
Friday, October 30
Lecture · Pharmacology
Achieving Benzodiazepine Withdrawal in Older Adults: Best Practices for Success
Individualized slow-taper strategies for benzodiazepine deprescribing in older adults, accounting for social context. Pharmacology-eligible.
Saturday, October 31
Lecture · Medicine Management
Polypharmacy Management in Older Adults: A Systematic Literature Review and Implications for Psychiatric Nursing Practice
Systematic review of deprescribing and Beers Criteria use, highlighting psychiatric nurses' role in spotting medication risks in older adults. Pharmacology-eligible.
Other topics at this meeting
Practice, Policy & Workforce 14Child & Adolescent 8Measurement-Based Care & Diagnosis 7Substance Use Disorders 7Emergency & Acute Psychiatry 6Opioid Use Disorder 5Perinatal & Women's Mental Health 5Suicide & Self-Harm 5Education & Training 4Forensic & Correctional 4PTSD & Trauma 4Autism & Neurodevelopmental Disorders 3